The Wall Street bank reiterated a Buy rating for Palantir and raised its forecast from $125 per share to $150, implying ...

What comes next for Palantir stock is pain for shareholders. The stock may not fall, but it certainly will not go up by 1,000 ...

The stock is clearly overvalued at today's prices. 2025 has been one of the most manic-depressive stock markets in history.

Palantir shares closed at a record high Wednesday for the second consecutive day, as a cooling of global trade tensions has ...

Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...

Nabeel Qureshi said Palantir screened for three particular types of people very carefully.

Shares of Palantir closed at an all-time high as optimism about easing tariffs has driven artificial intelligence stocks ...

With a market cap of $300 billion, Palantir (PLTR) is among the 10 largest tech stocks in the U.S. The enterprise-facing data ...

Another notable buy includes CRISPR Therapeutics AG (NASDAQ: CRSP ), with ARKK ETF purchasing 31,983 shares, reflecting a continued investment in the gene-editing company with a total dollar value of ...

The first headline of the day came via insider filing. The disclosure showed a large open-market purchase by Heather ...

We recently published a list of the 13 Best High Volume Stocks to Buy Now. In this article, we are going to take a look at ...

Palantir Technologies shares have surged 19% over the past week. The rally follows the company's better-than-expected Q1 ...